Key data
| Regulation | Commission Implementing Regulation (EU) 2026/2526, of 13 November 2026 |
|---|---|
| Publication | 16 November 2026 (Official Journal of the EU, reference OJ:L_202602526) |
| Entry into force | Not specified in the published regulation |
| Affected parties | Manufacturers, distributors and professional users of the biocide Manorapid express GEL in the EU |
| Category | European Regulation — Biocides |
| Repealed regulation | Commission Implementing Regulation (EU) 2023/1106 (original product authorization) |
If your company uses, distributes or manufactures the disinfectant Manorapid express GEL, you must act immediately. The Commission Implementing Regulation (EU) 2026/2526, published on 16 November 2026, cancels the Union-wide authorization for this biocide and repeals Commission Implementing Regulation (EU) 2023/1106, which was the regulation that had originally authorized it.
This is not a labeling change or a partial restriction: it is a total cancellation of the marketing authorization across the entire European market. Continuing to use or distribute the product after the established deadlines exposes the company to administrative penalties.
What does this regulation establish?
Commission Implementing Regulation (EU) 2026/2526 adopts a decision to cancel the Union-wide authorization for the biocide Manorapid express GEL, in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council, which regulates the marketing and use of biocides in the EU.
| Concept | Previous situation | Situation after Regulation 2026/2526 |
|---|---|---|
| Marketing authorization | In force (Commission Implementing Regulation EU 2023/1106) | Cancelled throughout the EU |
| Reference regulation | Commission Implementing Regulation (EU) 2023/1106 | Repealed by Regulation 2026/2526 |
| Marketing by the authorization holder | Permitted | Prohibited |
| Use by distributors and professional users | Permitted | Must cease in accordance with established deadlines |
The cancellation means that the authorization holder cannot continue placing the product on the European market. Companies that have it in stock or in their disinfection protocols must plan its removal and replacement with alternative products that have current authorization.
Economic and operational impact
The impact is not only regulatory compliance: it has direct operational consequences for any company that has integrated Manorapid express GEL into its disinfection processes.
- Product replacement cost: Companies must identify and contract an alternative authorized biocide, which may involve changes in suppliers, renegotiation of contracts and possible price differences.
- Stock management: Current stock of Manorapid express GEL must be removed in accordance with the deadlines established by the regulation. Depending on the volume stored, this may involve disposal or return costs to the supplier.
- Protocol updates: Sectors such as hospitality, healthcare and food industry have documented disinfection protocols. Changing the product involves updating those documents, usage methods and, in some cases, internal validations.
- Penalty risk: Non-compliance may result in administrative penalties from the competent authorities of each Member State. Spanish regulations on biocides assign sanctioning authority to the autonomous communities and the Spanish Agency for Medicines and Health Products (AEMPS).
Who does it affect?
- Manufacturers and authorization holders: Obliged to cease marketing the product throughout the EU.
- Distributors and wholesalers: Must remove the product from their catalogs and manage existing stock in accordance with regulatory deadlines.
- Hospitality sector: Hotels, restaurants and catering companies that use this disinfectant in their hygiene protocols must replace it.
- Healthcare sector: Clinics, hospitals, primary care centers and residential facilities that use Manorapid express GEL in surface or instrument disinfection.
- Food industry: Companies with HACCP or industrial hygiene protocols that include this biocide must update their documentation and change products.
- Professional users in general: Any company or professional that acquires and uses this biocide in the exercise of their activity.
Practical example
A restaurant chain with 15 locations in Spain uses Manorapid express GEL as a surface disinfectant in kitchens and food handling areas. Following the publication of Regulation 2026/2526, the chain must:
- Identify the volume of Manorapid express GEL stock in each location and in its central warehouse.
- Locate an alternative biocide with current authorization in the EU for the same type of use (surface disinfection in contact with food).
- Update product sheets in its HACCP management system and in the cleaning and disinfection protocols of each location.
- Manage the removal of current stock in accordance with the deadlines established by the regulation, avoiding its use once the permitted deadline has passed.
If the chain does not act and a health inspector detects the use of the canceled product, the company is exposed to a sanctioning proceeding by the competent autonomous authority.
What should companies do now?
- Verify if they use Manorapid express GEL: Review inventories, disinfection protocols and supply contracts to confirm if the product is present in operations.
- Cease acquisition of new units: Do not place any more orders for the product from suppliers or distributors.
- Identify an alternative authorized biocide: Consult the ECHA register of authorized biocides or contact your usual supplier to obtain an alternative with current authorization for the same type of use.
- Manage existing stock: Plan the removal of stocks in accordance with the deadlines established by the regulation. If the entry into force date is not specified, act with maximum diligence and do not wait until the last moment.
- Update protocols and documentation: Modify hygiene protocols, HACCP sheets, disinfection records and any internal document that references this product.
- Inform the team: Communicate the change to those responsible for purchasing, quality, production and any employee who manages or applies disinfectant products.
Frequently asked questions
Can I continue using the Manorapid express GEL stock I have stored?
The regulation establishes that companies must cease use and remove stocks in accordance with the deadlines set by Commission Implementing Regulation (EU) 2026/2526. Given that the entry into force date is not specified in the published data, it is recommended to act with maximum diligence and not exhaust stock without having already identified an alternative authorized product. Continuing to use the product after the established deadlines may result in administrative penalties.
What happens if I don't remove Manorapid express GEL and health authorities inspect me?
Non-compliance may result in administrative penalties from the competent authorities of each Member State. In Spain, sanctioning authority in matters of biocides corresponds to the autonomous communities and AEMPS. The severity of the penalty will depend on the applicable national legislation and the degree of non-compliance detected.
What regulation originally authorized Manorapid express GEL and what replaces it?
The original authorization was granted by Commission Implementing Regulation (EU) 2023/1106. The new Commission Implementing Regulation (EU) 2026/2526, published on 16 November 2026, cancels that authorization and expressly repeals Regulation 2023/1106. There is no replacement regulation that authorizes the same product: the cancellation is definitive.
Where can I find alternative biocides authorized in the EU?
The European Chemicals Agency (ECHA) maintains a public register of biocides authorized in the EU, accessible on its official website. You can also consult with your usual disinfection product supplier or with AEMPS in Spain to identify alternatives with current authorization for the same type of use.
Does this cancellation only affect Spain or the entire EU?
The cancellation is of the Union-wide authorization, which means it has effect in all Member States of the European Union. This is not a national restriction: no manufacturer, distributor or professional user in the EU can continue marketing or using the product once the established deadlines have passed.
Official source
Consult complete regulation in official source
Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602526